Rapamycin, 42-O-(2-hydroxyethyl)-

CAS: 159351-69-6

Ref. AN-AG001QMG

Información del producto

• Nombre: Rapamycin, 42-O-(2-hydroxyethyl)-
• Sinónimos: [u'001, RAD', u'40-O-(2-hydroxyethyl)-rapamycin', u'Afinitor', u'Certican', u'everolimus', u'RAD 001', u'RAD, SDZ', u'RAD001', u'SDZ RAD', u'SDZ-RAD', u'Everolimus', u'Afinitor', u'Certican', u'Zortress', u'RAD001', u'SDZ-RAD', u'42-O-(2-Hydroxyethyl)rapamycin', u'159351-69-6', u'40-O-(2-hydroxyethyl)-rapamycin', u'Afinitor Disperz', u'CHEBI:68478', u'UNII-9HW64Q8G6G', u'RAD 001', u'9HW64Q8G6G', u'RAD-001', u'NCGC00167512-01', u'(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone', u'Votubia', u'RAD', u'XIENCE V', u'(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone', u'(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone', u'(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,35R)-1,18-dihydroxy-12-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone', u'(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone', u'Everolimus (RAD001)', u'everolimusum', u'NSC733504', u'Everolimus (INN)', u'Everolimus [USAN]', u'Everolimus(RAD001)', u'PubChem20048', u'Everolimus - RAD001', u'SCHEMBL4378', u'DSSTox_CID_20599', u'DSSTox_RID_79508', u'DSSTox_GSID_40599', u'Everolimus [USAN:INN:BAN]', u'NVP-RAD-001', u'Everolimus, analytical standard', u'GTPL5889', u'RAD-001C', u'CHEMBL1908360', u'DTXSID0040599', u'HSDB 8255', u'Everolimus; RAD001; SDZ-RAD', u'HKVAMNSJSFKALM-GKUWKFKPSA-N', u'C53H83NO14', u'EX-A2057', u'Tox21_112510', u'BDBM50088378', u'AKOS015850977', u'ZINC169677008', u'CS-0064', u'DB01590', u'RL02051', u'AS-16971', u'AT-22180', u'HY-10218', u'LS-143292', u'CAS-159351-69-6', u'V2036', u'351E696', u'Q-101413', u'BRD-K13514097-001-01-2', u'BRD-K13514097-001-05-3', u'dihydroxy-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-dimethoxy-hexamethyl-[?]pentone'], (3S,6R,7Z,9R,10R,12R,14S,15E,17Z,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-1-methylethyl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine, rapamycin deriv., 40-O-(2-Hydroxyethyl)rapamycin, 42-O-(2-Hydroxy)ethyl rapamycin, 42-O-(2-Hydroxyethyl)-rapamycin, Afinitor, Afinitor Disperz, Certica, Certican, Certican(R), RAD, Rad-001, Sdz-Rad, Sdzrad, Votubia, Xience, Xience V, Zortress
• CAS: 159351-69-6
• Marca: Indagoo

Propiedades químicas

• Peso molecular: 958.2244
• Fórmula: C₅₃H₈₃NO₁₄
• Pureza: 98%
• Color/Forma: Solid
• InChI: InChI=1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1
• Clave InChI: HKVAMNSJSFKALM-GKUWKFKPSA-N